by Scott Larrivee | Nov 27, 2023 | Industry News
From MedicalXpress: A team of researchers has developed a new method that suppresses the distribution of drugs to healthy tissues and also rapidly removes the drugs once distributed in the body, which could improve the accuracy of imaging diagnosis of difficult...
by Scott Larrivee | Sep 28, 2023 | News
NEW YORK – September 28, 2023 – Nusano, Inc., a company reshaping the production of cancer-fighting radioisotopes, today announced that senior management will participate in the following investor conferences in October. William Blair Virtual Radiopharma Conference...
by Scott Larrivee | Sep 15, 2023 | News
Executive with three decades of successful multinational operations and commercial experience to lead launch of proprietary radioisotope production platform VALENCIA, Calif. – Sept. 15, 2023 – Nusano, Inc., a company reshaping the production of cancer-fighting...
by Scott Larrivee | Sep 12, 2023 | Industry News
News from the United Kingdom’s Institute of Cancer Research (ICR) published in The Lancet Oncology reports that targeted radiation treatment is “greatly improving” the quality of life for cancer patients. ICR writes: Patients with advanced prostate...
by Scott Larrivee | Aug 22, 2023 | News
With many now expecting radiopharmaceuticals to grow into a $20-30 billion market, investors are increasingly looking at the obstacles and opportunities for suppliers and drugmakers in this space. To advance these discussions, on Friday, May 12, 2023, Nusano and...
